Decades of research indicate that cannabinoids like CBD interact with the body’s endocannabinoid system, a complex system that contributes to a variety of biological processes like inflammation responses, relaxation, sleeping, and appetite. By linking with the two main types of cannabinoid receptors, CB1 and CB2, which are found on cells throughout the body, CBD interacts with the endocannabinoid system, helping it in the regulation of homeostasis — the body’s natural state of balance.
Look, I’m no square. I’m not here to rain on anybody’s parade. But damn, let’s call CBD coffee what it is: a phase that was brought to fruition by a newfound excitement for America turning green. There are plenty of solid CBD and THC-infused products out there (for what it’s worth, I think THC coffee is a total blast), but let’s be reasonable. So next time you’re at a painfully hip coffee shop in Bushwick that specializes in CBD coffee, ask yourself: do I want to feel weird today?
While marijuana – including CBD (cannabidiol) oil products made from marijuana – must comply with seed-to-sale state laws that make these products illegal to transport across state lines, hemp – whether hemp oil, hemp nuts or hemp supplement oils that are highly concentrated with CBD- is perfectly legal for use throughout the United States, as long as the hemp is imported from an international source. (Hemp oil grown in the United States is subject to the same seed-to-sale state laws that apply to marijuana.)
Let's start with the most officially proven medical use of CBD. Earlier this year, the FDA approved the first-ever drug containing CBD, Epidiolex, to treat two rare forms of pediatric epilepsy. To get to that point, the drug's manufacturers had to do a whole lot of randomized, placebo-controlled trials on humans. They had to study how much children could take, what would happen in case of overdose, and any possible side effects that would occur.
Jump up ^ Devinsky, Orrin; Cilio, Maria Roberta; Cross, Helen; Fernandez-Ruiz, Javier; French, Jacqueline; Hill, Charlotte; Katz, Russell; Di Marzo, Vincenzo; Jutras-Aswad, Didier; Notcutt, William George; Martinez-Orgado, Jose; Robson, Philip J.; Rohrback, Brian G.; Thiele, Elizabeth; Whalley, Benjamin; Friedman, Daniel (22 May 2014). "Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders". Epilepsia. 55 (6): 791–802. doi:10.1111/epi.12631. PMC 4707667. PMID 24854329.